Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes Epidemiology and risk factors

被引:76
作者
Giorda, Carlo B. [1 ]
Avogaro, Angelo [2 ]
Maggini, Marina [3 ]
Lombardo, Flavia [3 ]
Mannucci, Edoardo [4 ,5 ]
Turco, Salvatore [9 ]
Alegiani, Stefania Spila [4 ,5 ]
Raschetti, Roberto [4 ,5 ]
Velussi, Mario [6 ]
Ferrannini, Ele [7 ,8 ]
机构
[1] Metab & Diabet Unit, Regione Piemonte, Chieri, Italy
[2] Univ Padua, Div Metab Dis, Padua, Italy
[3] Natl Inst Hlth, Rome, Italy
[4] Univ Florence, Florence, Italy
[5] Azienda Osped Careggi, Florence, Italy
[6] Casa Cura Pineta Carso, Trieste, Italy
[7] Univ Pisa, Sch Med, Inst Clin Physiol, Dept Internal Med, I-56100 Pisa, Italy
[8] Univ Pisa, Sch Med, Inst Clin Physiol, CNR, I-56100 Pisa, Italy
[9] Univ Naples Federico II, Naples, Italy
关键词
D O I
10.2337/dc08-1013
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - The purpose of this study was to assess incidence of and risk factors for recurrent cardiovascular disease (CVD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - We estimated the incidence of recurrent cardiovascular events in type 2 diabetic patients, aged 40-97 years, followed by a network of diabetes clinics. The analysis was conducted separately for 2,788 patients with CVD at enrollment (cohort A) and for 844 patients developing the first episode during the observation period (cohort B). RESULTS - During 4 years of follow-up, in cohort A the age-adjusted incidence of a recurrent event (per 1,000 person-years) was 72.7 (95% CI 58.3-87.1) in men and 32.5 (21.2-43.7) in women, whereas in cohort B it was 40.1 (17.4-62.9) in men and 22.4 (12.9-32.0) in women. After controls were included for potential predictors (familial CVD, obesity, smoking, diabetes duration, glycemic control, microvascular complications, geographic area, and antihypertensive and lipid-lowering treatment), male sex, older age, and insulin use were significant independent risk predictors (cohort A) and serum triglyceride levels >= 1.69 mmol/l emerged as the only metabolic (negative) prognostic factor (cohort B). in both cohorts, a prior CVD episode, especially myocardial infarction, was by far the strongest predictor of recurrent CVD. CONCLUSIONS - Approximately 6% of unselected diabetic patients in secondary prevention develop recurrent major CVD every year. Those with long-standing previous CVD show a higher incidence of recurrence. Male sex, age, high triglyceride levels, and insulin use are additional predictors of recurrence.
引用
收藏
页码:2154 / 2159
页数:6
相关论文
共 24 条
[1]
THE IMPACT OF DIABETES ON SURVIVAL FOLLOWING MYOCARDIAL-INFARCTION IN MEN VS WOMEN [J].
ABBOTT, RD ;
DONAHUE, RP ;
KANNEL, WB ;
WILSON, PWF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (23) :3456-3460
[2]
The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI study [J].
Avogaro, A ;
Giorda, C ;
Maggini, M ;
Mannucci, E ;
Raschetti, R ;
Sarli, E ;
Spila-Alegiani, S ;
Turco, S ;
Velussi, M .
DIABETIC MEDICINE, 2004, 21 (07) :738-745
[3]
Incidence of coronary heart disease in type 2 diabetic men and women - Impact of microvascular complications, treatment, and geographic location [J].
Avogaro, Angelo ;
Giorda, Carlo ;
Maggini, Marina ;
Mannucci, Edoardo ;
Raschetti, Roberto ;
Lombardo, Flavia ;
Spila-Alegiani, Stefania ;
Turco, Salvatore ;
Velussi, Mario ;
Ferrannini, Ele .
DIABETES CARE, 2007, 30 (05) :1241-1247
[4]
THE PREVALENCE OF DIABETES IN ELDERLY PEOPLE [J].
CROXSON, SCM ;
BURDEN, AC ;
BODINGTON, M ;
BOTHA, JL .
DIABETIC MEDICINE, 1991, 8 (01) :28-31
[5]
Bias [J].
Delgado-Rodríguez, M ;
Llorca, J .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2004, 58 (08) :635-641
[6]
The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction - Results from the PROactive (PROactive 05) study [J].
Erdmann, Erland ;
Dormandy, John A. ;
Charbonnel, Bernard ;
Massi-Benedetti, Massimo ;
Moules, Ian K. ;
Skene, Allan M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (17) :1772-1780
[7]
Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) trial [J].
Frishman, WH ;
Gomberg-Maitland, M ;
Hirsch, H ;
Catanese, J ;
Furia-Palazzo, S ;
Mueller, H ;
Steingart, R ;
Forman, S .
CLINICAL CARDIOLOGY, 1998, 21 (03) :184-190
[8]
Incidence and risk factors for stroke in type 2 diabetic patients - The DAI study [J].
Giorda, Carlo Bruno ;
Avogaro, Angelo ;
Maggini, Marina ;
Lombardo, Flavia ;
Mannucci, Edoardo ;
Turco, Salvatore ;
Alegiani, Stefania Spila ;
Raschetti, Roberto ;
Velussi, Mario ;
Ferrannini, Ele .
STROKE, 2007, 38 (04) :1154-1160
[9]
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[10]
INTERNATIONAL CRITERIA FOR THE DIAGNOSIS OF DIABETES AND IMPAIRED GLUCOSE-TOLERANCE [J].
HARRIS, MI ;
HADDEN, WC ;
KNOWLER, WC ;
BENNETT, PH .
DIABETES CARE, 1985, 8 (06) :562-567